Brevan Howard Capital Management LP Purchases 10,094 Shares of Tenet Healthcare Co. (NYSE:THC)

Brevan Howard Capital Management LP raised its holdings in Tenet Healthcare Co. (NYSE:THC - Free Report) by 72.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 24,064 shares of the company's stock after acquiring an additional 10,094 shares during the quarter. Brevan Howard Capital Management LP's holdings in Tenet Healthcare were worth $3,038,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in THC. Geode Capital Management LLC lifted its stake in Tenet Healthcare by 3.5% in the fourth quarter. Geode Capital Management LLC now owns 2,116,121 shares of the company's stock valued at $268,591,000 after buying an additional 71,454 shares during the period. Norges Bank acquired a new stake in shares of Tenet Healthcare in the 4th quarter valued at approximately $190,819,000. Dimensional Fund Advisors LP grew its holdings in Tenet Healthcare by 22.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,493,532 shares of the company's stock valued at $188,524,000 after purchasing an additional 272,906 shares during the period. AQR Capital Management LLC increased its stake in Tenet Healthcare by 20.8% in the fourth quarter. AQR Capital Management LLC now owns 872,117 shares of the company's stock valued at $110,087,000 after purchasing an additional 150,361 shares in the last quarter. Finally, Northern Trust Corp boosted its position in shares of Tenet Healthcare by 22.0% during the fourth quarter. Northern Trust Corp now owns 848,049 shares of the company's stock worth $107,049,000 after purchasing an additional 152,671 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company's stock.

Tenet Healthcare Stock Up 0.7 %

NYSE:THC opened at $149.01 on Tuesday. The firm has a market capitalization of $13.84 billion, a price-to-earnings ratio of 4.62, a price-to-earnings-growth ratio of 1.02 and a beta of 1.63. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. Tenet Healthcare Co. has a twelve month low of $109.82 and a twelve month high of $171.20. The stock's 50 day moving average price is $127.44 and its two-hundred day moving average price is $136.00.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $4.36 EPS for the quarter, beating analysts' consensus estimates of $3.11 by $1.25. The firm had revenue of $5.22 billion during the quarter, compared to analysts' expectations of $5.15 billion. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. The company's revenue for the quarter was down 2.5% compared to the same quarter last year. During the same quarter last year, the company posted $3.22 earnings per share. Equities research analysts expect that Tenet Healthcare Co. will post 12.24 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director J Robert Kerrey sold 9,525 shares of Tenet Healthcare stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the transaction, the director now directly owns 27,378 shares in the company, valued at approximately $3,434,022.54. The trade was a 25.81 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.81% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently commented on THC. Royal Bank of Canada raised their price objective on Tenet Healthcare from $183.00 to $189.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 30th. The Goldman Sachs Group lifted their price objective on Tenet Healthcare from $134.00 to $154.00 and gave the company a "neutral" rating in a report on Monday. Baird R W cut Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. StockNews.com upgraded shares of Tenet Healthcare from a "hold" rating to a "buy" rating in a report on Thursday, May 1st. Finally, Morgan Stanley raised their price objective on shares of Tenet Healthcare from $165.00 to $175.00 and gave the stock an "overweight" rating in a report on Monday. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. According to data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $173.69.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.